NCT00620165View on ClinicalTrials.gov

Efficacy of Levetiracetam in Essential Tremor

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Essential Tremor
Interventions
DRUG

levetiracetam

Subjects will receive levetiracetam titrated up over 6 weeks to a maximum dose of 3000 milligrams (mg) per day, and then continue at 1500 mg twice daily for an additional 6 weeks.

DRUG

placebo

Subjects will receive identical placebo titrated up over 6 weeks to a maximum daily dose, and then continue twice daily for an additional 6 weeks.

Trial Locations (1)

90822

VA Long Beach Healthcare System, Long Beach

All Listed Sponsors
lead

Southern California Institute for Research and Education

OTHER

NCT00620165 - Efficacy of Levetiracetam in Essential Tremor | Biotech Hunter | Biotech Hunter